Nalaganje...
Lanthanum carbonate to control plasma and urinary oxalate level in type 1 primary hyperoxaluria?
INTRODUCTION: The therapy to reduce urinary oxalate excretion in primary hyperoxaluria type 1 is still required. CASE PRESENTATION: A 37‐year‐old hemodialyzed man suffered from systemic oxalosis secondary to primary hyperoxaluria type 1 exhibited a drastic plasma oxalate decrease from 110 to 22 µmol...
Shranjeno v:
| izdano v: | IJU Case Rep |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8255283/ https://ncbi.nlm.nih.gov/pubmed/34258537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iju5.12296 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|